BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 73 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $69,323 | +4.1% | 36,679 | -0.9% | 0.00% | – |
| Q4 2022 | $66,611 | -28.4% | 37,006 | -32.7% | 0.00% | – |
| Q3 2022 | $93,000 | -62.9% | 54,978 | -46.2% | 0.00% | – |
| Q2 2022 | $251,000 | -50.0% | 102,126 | -43.6% | 0.00% | – |
| Q1 2022 | $502,000 | -28.7% | 181,097 | +37.0% | 0.00% | – |
| Q4 2021 | $704,000 | -34.0% | 132,156 | +4.8% | 0.00% | – |
| Q3 2021 | $1,067,000 | -54.7% | 126,106 | -34.8% | 0.00% | -100.0% |
| Q2 2021 | $2,358,000 | +15.0% | 193,462 | +128.9% | 0.00% | 0.0% |
| Q1 2021 | $2,051,000 | -11.4% | 84,528 | +17.0% | 0.00% | 0.0% |
| Q4 2020 | $2,316,000 | +873.1% | 72,256 | +817.9% | 0.00% | – |
| Q3 2020 | $238,000 | -66.9% | 7,872 | -53.7% | 0.00% | – |
| Q2 2020 | $718,000 | -68.0% | 17,017 | -81.1% | 0.00% | -100.0% |
| Q1 2020 | $2,246,000 | – | 90,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $110,568,000 | 2.92% |
| Boxer Capital, LLC | 2,014,858 | $64,576,000 | 2.08% |
| RA Capital Management | 2,589,904 | $83,006,000 | 1.16% |
| Artal Group S.A. | 1,646,517 | $52,771,000 | 1.13% |
| Burrage Capital Management LLC | 34,891 | $1,118,000 | 0.85% |
| Bellevue Group AG | 1,403,000 | $44,967,000 | 0.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $25,720,000 | 0.51% |
| Ikarian Capital, LLC | 293,941 | $9,421,000 | 0.42% |
| Avoro Capital Advisors LLC | 640,000 | $20,512,000 | 0.35% |
| Logos Global Management LP | 123,465 | $3,957,000 | 0.34% |